اليوم السابع
اليوم السابع
Ready to play
Ready to play
The article focused on the Egyptian Drug Authority's achievements in developing the pharmaceutical industry, highlighting that the Egyptian market has become more attractive to investors thanks to the simplification of drug registration procedures, which now take between 3 to 6 months—provided the dossier is complete—compared to longer durations in the past. The report also noted that Egypt currently has five factories producing vaccines and biopharmaceuticals, whereas before 2022 there was only one factory. Additionally, 94% of the medicines available in the market are primarily locally manufactured, the highest in the Middle East and Africa, surpassing countries like Germany, where the local manufacturing rate reaches 70%. The Authority also introduced clear and transparent pricing mechanisms allowing companies to forecast and adjust their prices according to economic changes, aimed at supporting the stability of the pharmaceutical industry and ensuring the delivery of medicines to Egyptian patients. These improvements are part of efforts to enhance production sustainability and bolster the local industry to confront economic challenges.
Notice: This Is an AI-Generated Summary
Comments (0)